Provider of therapeutic drug development services intended to offer bio-available forms of approved drugs. The company's services include developing drugs using green chemistry to design drugs that are bioavailable, enabling researchers to develop oral drugs.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Seed Round | 21-Oct-2011 | $300K | 00000 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Robert Bettigole | Chief Executive Officer, President, Treasurer & Chairman |
Name | Representing | Role | Since |
---|---|---|---|
Brian Dixon | Occam Sciences | Board Member | 000 0000 |
David Whittaker MD | Elm Street Ventures | Board Member | 000 0000 |
John Warner | Occam Sciences | Board Member | 000 0000 |
Joseph Pont | Occam Sciences | Board Member | 000 0000 |
Robert Bettigole | Self | Chief Executive Officer, President, Treasurer & Chairman | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Elm Street Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Warner Babcock Institute for Green Chemistry | Other | Minority | 000 0000 | 000000 0 |